Published in J Clin Pharmacol on December 01, 1987
Assessing analgesic actions of opioids by experimental pain models in healthy volunteers - an updated review. Br J Clin Pharmacol (2009) 1.22
Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine. Br J Clin Pharmacol (1991) 1.10
Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers. Br J Clin Pharmacol (1991) 0.97
A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine. Br J Clin Pharmacol (1991) 0.85
Infants and young children metabolise codeine to morphine. A study after single and repeated rectal administration. Br J Clin Pharmacol (1992) 0.82
Bioanalytical method validation--a revisit with a decade of progress. Pharm Res (2000) 6.83
The component fatty acids of rat body fats. Biochem J (1933) 6.29
The body fats of the hen. Biochem J (1934) 3.08
Development and evaluation of an activity rating scale for disorders of the knee. Am J Sports Med (2001) 2.33
Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists. Hum Pathol (2001) 2.31
Mixed epithelial and stromal tumor of the kidney. Am J Surg Pathol (2000) 2.24
Patients' expectations of knee surgery. J Bone Joint Surg Am (2001) 2.14
Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother (1984) 2.09
Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet (1986) 2.07
False-positive results with chemically modified anti-D. Transfusion (1987) 1.93
Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms. Mod Pathol (2001) 1.92
Reliability, validity, and responsiveness of four knee outcome scales for athletic patients. J Bone Joint Surg Am (2001) 1.85
Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians: the Strong Heart Study. Am J Med (2001) 1.78
First-pass metabolism of cyclosporin by the gut. Lancet (1991) 1.71
Intravenous iron supplementation in end-stage renal disease patients. Am J Kidney Dis (1999) 1.57
Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev (2000) 1.44
Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Perit Dial Int (1991) 1.42
Codeine kinetics as determined by radioimmunoassay. Clin Pharmacol Ther (1977) 1.38
Cefotaxime and desacetyl cefotaxime kinetics in renal impairment. Clin Pharmacol Ther (1985) 1.34
Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes. Clin Pharmacol Ther (1997) 1.33
Pharmacokinetics of cefepime in subjects with renal insufficiency. Clin Pharmacol Ther (1990) 1.32
Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients. Am J Med (1987) 1.30
Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin. Antimicrob Agents Chemother (1990) 1.28
Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet (2001) 1.26
Morphine in cow and human milk: could dietary morphine constitute a ligand for specific morphine (mu) receptors? Science (1981) 1.26
Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics. J Proteomics (2010) 1.23
Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitis. Am J Kidney Dis (1987) 1.23
Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease. Clin Pharmacol Ther (1992) 1.23
Plasma codeine and morphine concentrations after therapeutic oral doses of codeine-containing analgesics. Clin Pharmacol Ther (1978) 1.22
Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta. Clin Pharmacol Ther (1991) 1.22
Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers. Antimicrob Agents Chemother (1992) 1.16
A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis (1995) 1.14
Whole-bowel irrigation as a treatment for acute lithium overdose. Ann Emerg Med (1991) 1.14
Disposition of the cephalosporin cefepime in normal and renally impaired subjects. Drug Metab Dispos (1991) 1.13
A primer on continuous renal replacement therapy for critically ill patients. Ann Pharmacother (1998) 1.10
Proximal-row carpectomy for diseases of the proximal row. J Bone Joint Surg Am (1977) 1.10
Acute oxalate nephropathy after massive ascorbic acid administration. Arch Intern Med (1985) 1.09
Validity of creatinine clearance estimates in the assessment of renal function. Clin Pharmacol Ther (1990) 1.07
Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects. Eur J Clin Pharmacol (1981) 1.06
Mixed epithelial and stromal tumor of the kidney lacks the genetic alterations of cellular congenital mesoblastic nephroma. Hum Pathol (2001) 1.05
Marfan syndrome. Demonstration of abnormal elastin in aorta. J Clin Invest (1982) 1.05
Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia. Circulation (1998) 1.04
Unintended immunomodulation: part II. Effects of pharmacological agents on cytokine activity. Shock (2000) 1.04
Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests. Radiology (2000) 1.04
Synthesis of soluble elastin by aortic medial cells in culture. Biochem Biophys Res Commun (1974) 1.02
Cefazolin as empiric therapy in hemodialysis-related infections: efficacy and blood concentrations. Am J Kidney Dis (1998) 1.02
Metanephric adenoma-like tumors of the kidney: report of 3 malignancies with emphasis on discriminating features. Arch Pathol Lab Med (1999) 1.01
Mapping a tumor suppressor gene to chromosome 2p13 in metanephric adenoma by microsatellite allelotyping. Hum Pathol (2001) 1.01
A review of disorders of water homeostasis in psychiatric patients. Psychosomatics (1991) 1.00
Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-up. Urology (2000) 0.99
Disposition of gabapentin in anuric subjects on hemodialysis. J Clin Pharmacol (1995) 0.99
Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother (1984) 0.99
The chemistry of 9 ,19-cyclo steroid derivatives. J Org Chem (1972) 0.99
Codeine disposition in smokers and nonsmokers. Clin Pharmacol Ther (1982) 0.99
Analgesic drugs in breast milk and plasma. Clin Pharmacol Ther (1981) 0.98
Determination of residual renal function with iohexol clearance in hemodialysis patients. Kidney Int (1996) 0.98
Palpable prostatic nodules: comparison of US and digital guidance for fine-needle aspiration biopsy. Radiology (1989) 0.96
Medication knowledge and compliance among patients receiving long-term dialysis. Am J Health Syst Pharm (1995) 0.96
Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipients. Am J Nephrol (1985) 0.95
The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites. Pharm Res (1991) 0.95
Comparative disposition of codeine and pholcodine in man after single oral doses. Br J Clin Pharmacol (1986) 0.94
Inflammatory pseudotumor of the urinary bladder: a report of five cases and review of the literature. Can J Urol (2001) 0.94
Marfan's syndrome: structural, biochemical, and mechanical studies of the aortic media. J Lab Clin Med (1985) 0.94
Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis. Am J Kidney Dis (1998) 0.93
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls. Acta Neurol Scand Suppl (2012) 0.93
Disposition of vancomycin during hemofiltration. Clin Pharmacol Ther (1986) 0.93
Effects of probenecid and cimetidine on renal disposition of ofloxacin in rats. Antimicrob Agents Chemother (1998) 0.93
Treating severe metabolic alkalosis. Clin Pharm (1983) 0.92
Predicting and preventing pressure ulcers in adults with paralysis. Adv Wound Care (1998) 0.92
Pharmacokinetics and O-dealkylation of morphine-3-alkyl ethers in the rat. A radioimmunoassay study. Drug Metab Dispos (1983) 0.92
Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy. AIDS (2000) 0.92
Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med (1992) 0.92
Anemia, iron storage and ceruloplasmin in copper nutrition in the growing rat. J Nutr (1973) 0.91
Renal oncocytoma and chromophobe renal cell carcinoma. A comparison of colloidal iron staining and electron microscopy. Am J Clin Pathol (1999) 0.91
Patient suicide in psychiatry residency programs : a national survey of training and postvention practices. Acad Psychiatry (1998) 0.91
Effect of bilateral nephrectomy on active renin, angiotensinogen, and renin glycoforms in plasma and myocardium. Hypertension (1997) 0.90
Should intravenous immunoglobulin G be first-line treatment for acute thrombotic thrombocytopenic purpura? Case report and review of the literature. Am J Kidney Dis (1991) 0.90
Codeine dosage in renal failure. Clin Pharm (1986) 0.90
No evidence for linkage at candidate type 2 diabetes susceptibility loci on chromosomes 12 and 20 in United Kingdom Caucasians. J Clin Endocrinol Metab (2000) 0.90
Excretion of drugs in human breast milk. Drug Metab Rev (1981) 0.89